Comparison of 30-Day Mortality After Diagnostic Coronary Angiography at VA and Community Hospitals

Denise M Hynes1,2,3, Diana J Govier4,5, Alex Hickok4

  • 1Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, OR, USA. denise.hynes@va.gov.

Insights

Veterans undergoing diagnostic coronary angiography (DCA) in community care (VACC) had higher 30-day mortality compared to VA facilities (VAF). Further research is needed to improve VACC follow-up and outcomes.

Area of Science:

  • Cardiology
  • Health Services Research
  • Outcomes Research

Background:

  • The US Department of Veterans Affairs (VA) provides care through its own facilities (VAF) and community care (VACC).
  • The comparative outcomes of diagnostic coronary angiography (DCA) between VAF and VACC are not well understood.
  • This study addresses the knowledge gap regarding DCA outcomes in VAF versus VACC.

Purpose of the Study:

  • To compare 30-day all-cause and cardiac-related mortality for DCA performed in VAF versus VACC.
  • To evaluate the safety and effectiveness of DCA delivery models within the VA system.

Main Methods:

  • Retrospective cohort study utilizing pooled cross-sectional analysis of 31,640 VA patients undergoing outpatient DCA from October 2015 to June 2019.
  • Patients were matched on nine baseline characteristics to ensure comparability between VAF and VACC groups.
  • Weighted regression adjustment was used to estimate average treatment outcomes for VACC, with sub-analyses stratified by valvular disease and heart failure diagnoses.

Main Results:

  • A higher proportion of DCAs (28.06%) were performed through VACC.
  • Patients undergoing DCA in VACC experienced significantly greater odds of 30-day all-cause (aOR 6.918), cardiac-related (aOR 6.112), and non-cardiac related (aOR 13.45) mortality compared to those in VAF.
  • These increased mortality risks associated with VACC DCA were consistent across all subgroups analyzed.

Conclusions:

  • Diagnostic coronary angiography in VACC settings is associated with increased 30-day mortality among VA patients.
  • There is a critical need to investigate strategies for enhancing patient follow-up and improving outcomes in VACC settings for DCA.
  • Optimizing care pathways for DCA within community care is essential for ensuring comparable patient safety and outcomes.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753